Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
作者： Michael T Brady , James M Oleske , Paige L Williams , Carol Elgie , Lynne M Mofenson
DOI: 10.1097/QAI.0B013E3181B9869F
关键词:
摘要: Context:Introduction of highly active antiretroviral therapy has significantly decreased mortality in HIV-1-infected adults and children. Although an increase non-HIV-related been noted adults, data children are limited.Objectives:To evaluate changes causes risk factors
cabdirect.org
sci-hub.se 参考文章(29)
ELAINE J. ABRAMS, JEREMY WEEDON, JEANNE BERTOLLI, KATIE BORNSCHLEGEL, JOSEPH CERVIA, HERMAN MENDEZ, GENEVIEVE LAMBERT, TEJINDER SINGH, PAULINE THOMAS, Aging cohort of perinatally human immunodeficiency virus-infected children in New York City Pediatric Infectious Disease Journal. ,vol. 20, pp. 511- 517 ,(2001) , 10.1097/00006454-200105000-00008
Steven L Gortmaker, Michael Hughes, Joseph Cervia, Michael Brady, George M Johnson, George R Seage III, Lin Ye Song, Wayne M Dankner, James M Oleske, None, Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. The New England Journal of Medicine. ,vol. 345, pp. 1522- 1528 ,(2001) , 10.1056/NEJMOA011157
Philimon Gona, Russell B. Van Dyke, Paige L. Williams, Wayne M. Dankner, Miriam C. Chernoff, Sharon A. Nachman, George R. Seage, Incidence of Opportunistic and Other Infections in HIV-Infected Children in the HAART Era JAMA. ,vol. 296, pp. 292- 300 ,(2006) , 10.1001/JAMA.296.3.292
R. M. Viani, W. M. Dankner, P. A. Muelenaer, S. A. Spector, Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatrics. ,vol. 104, pp. 1394- 1396 ,(1999) , 10.1542/PEDS.104.6.1394
Frank J. Palella, Rose K. Baker, Anne C. Moorman, Joan S. Chmiel, Kathleen C. Wood, John T. Brooks, Scott D. Holmberg, Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes. ,vol. 43, pp. 27- 34 ,(2006) , 10.1097/01.QAI.0000233310.90484.16
C. Langston, E. R. Cooper, J. Goldfarb, K. A. Easley, S. Husak, S. Sunkle, T. J. Starc, A. A. Colin, for the P2C2 HIV Study Group, Human immunodeficiency virus-related mortality in infants and children : Data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P2C2) study Pediatrics. ,vol. 107, pp. 328- 338 ,(2001) , 10.1542/PEDS.107.2.328
PatricioE. Ray, Lian Xu, Tamara Rakusan, Xue-Hui Liu, A 20-year history of childhood HIV-associated nephropathy Pediatric Nephrology. ,vol. 19, pp. 1075- 1092 ,(2004) , 10.1007/S00467-004-1558-1
Katja Doerholt, Trinh Duong, Pat Tookey, Karina Butler, Hermione Lyall, Mike Sharland, Vas Novelli, Andrew Riordan, David Dunn, A Sarah Walker, Diana M. Gibb, Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatric Infectious Disease Journal. ,vol. 25, pp. 420- 426 ,(2006) , 10.1097/01.INF.0000214994.44346.D3
ROSEMARY JOHANN-LIANG, JOSEPH S. CERVIA, GARY J. NOEL, Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s. Pediatric Infectious Disease Journal. ,vol. 16, pp. 1145- 1150 ,(1997) , 10.1097/00006454-199712000-00009
Susan Brogly, Paige Williams, George R Seage, James M Oleske, Russell Van Dyke, Kenneth McIntosh, PACTG 219C Team, Antiretroviral treatment in pediatric HIV infection in the United States: From clinical trials to clinical practice JAMA. ,vol. 293, pp. 2213- 2220 ,(2005) , 10.1001/JAMA.293.18.2213